Home NDC 21695-457 ERY-TAB
Product NDC 21695-457
11-digit product format 216950457
Labeler code 21695
Product ID 21695-457_e142a363-a8b8-40b9-ae9d-28777367e718
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name erythromycin
Dosage form TABLET, DELAYED RELEASE
Route ORAL
Labeler Rebel Distributors Corp
Application ANDA061621
Marketing category ANDA
Marketing start 1972-07-11
Marketing end 0000-00-00
Substance ERYTHROMYCIN
Active strength 333 mg/1
Pharmacologic classes Decreased Sebaceous Gland Activity [PE],Macrolide [EPC],Macrolide Antimicrobial [EPC],Macrolides [CS]
NDC exclude flag E
Listing certified through 2017-12-31
Current FDA listing Historical FDA.report record Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 2 · 88 matching rows.
View current auxiliary records. · View the auxiliary file history.
Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 2 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A061621-001 ERYTHROMYCIN ERYTHROMYCIN 250MG TABLET / ORAL AB Approved before 1982 A061621-002 ERYTHROMYCIN ERYTHROMYCIN 500MG TABLET / ORAL AB Approved before 1982
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 2 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 3 · 82 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 A061621-001 ERYTHROMYCIN 250MG TABLET / ORAL AB Approved before 1982 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A061621-002 ERYTHROMYCIN 500MG TABLET / ORAL AB Approved before 1982 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A061621-001 ERYTHROMYCIN 250MG TABLET / ORAL AB Approved before 1982 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A061621-002 ERYTHROMYCIN 500MG TABLET / ORAL AB Approved before 1982 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A061621-001 ERYTHROMYCIN 250MG TABLET / ORAL AB Approved before 1982 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A061621-002 ERYTHROMYCIN 500MG TABLET / ORAL AB Approved before 1982 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A061621-001 ERYTHROMYCIN 250MG TABLET / ORAL AB Approved before 1982 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A061621-002 ERYTHROMYCIN 500MG TABLET / ORAL AB Approved before 1982 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A061621-001 ERYTHROMYCIN 250MG TABLET / ORAL AB Approved before 1982 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A061621-002 ERYTHROMYCIN 500MG TABLET / ORAL AB Approved before 1982 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A061621-001 ERYTHROMYCIN 250MG TABLET / ORAL AB Approved before 1982 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A061621-002 ERYTHROMYCIN 500MG TABLET / ORAL AB Approved before 1982 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A061621-001 ERYTHROMYCIN 250MG TABLET / ORAL AB Approved before 1982 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A061621-002 ERYTHROMYCIN 500MG TABLET / ORAL AB Approved before 1982 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A061621-001 ERYTHROMYCIN 250MG TABLET / ORAL AB Approved before 1982 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A061621-002 ERYTHROMYCIN 500MG TABLET / ORAL AB Approved before 1982 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A061621-001 ERYTHROMYCIN 250MG TABLET / ORAL AB Approved before 1982 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A061621-002 ERYTHROMYCIN 500MG TABLET / ORAL AB Approved before 1982 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 A061621-001 ERYTHROMYCIN 250MG TABLET / ORAL AB Approved before 1982 d06236e962d9…2024-10-29 15:01 UTC 2024-10 A061621-002 ERYTHROMYCIN 500MG TABLET / ORAL AB Approved before 1982 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A061621-001 ERYTHROMYCIN 250MG TABLET / ORAL AB Approved before 1982 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A061621-002 ERYTHROMYCIN 500MG TABLET / ORAL AB Approved before 1982 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A061621-001 ERYTHROMYCIN 250MG TABLET / ORAL AB Approved before 1982 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A061621-002 ERYTHROMYCIN 500MG TABLET / ORAL AB Approved before 1982 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A061621-001 ERYTHROMYCIN 250MG TABLET / ORAL AB Approved before 1982 1e350fbaab3a…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A061621-002 ERYTHROMYCIN 500MG TABLET / ORAL AB Approved before 1982 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 A061621-001 ERYTHROMYCIN 250MG TABLET / ORAL AB Approved before 1982 8072bd15b7f6…2024-05-31 18:47 UTC 2024-05 A061621-002 ERYTHROMYCIN 500MG TABLET / ORAL AB Approved before 1982 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 A061621-001 ERYTHROMYCIN 250MG TABLET / ORAL AB Approved before 1982 5c6f7cd8ea54…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 A061621-002 ERYTHROMYCIN 500MG TABLET / ORAL AB RS, Approved before 1982 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 A061621-001 ERYTHROMYCIN 250MG TABLET / ORAL AB Approved before 1982 5d02ea3f76ae…2022-04-08 23:34 UTC 2022-04 A061621-002 ERYTHROMYCIN 500MG TABLET / ORAL AB RS, Approved before 1982 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 A061621-001 ERYTHROMYCIN 250MG TABLET / ORAL AB Approved before 1982 4b0b4de00fa7…2022-04-04 05:41 UTC 2022-04 A061621-002 ERYTHROMYCIN 500MG TABLET / ORAL AB RS, Approved before 1982 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 A061621-001 ERYTHROMYCIN 250MG TABLET / ORAL AB Approved before 1982 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 A061621-002 ERYTHROMYCIN 500MG TABLET / ORAL AB RS, Approved before 1982 74a2ff9319b5…2022-03-09 01:35 UTC 2022-03 A061621-001 ERYTHROMYCIN 250MG TABLET / ORAL AB Approved before 1982 bb7c543d1eb4…2022-03-09 01:35 UTC 2022-03 A061621-002 ERYTHROMYCIN 500MG TABLET / ORAL AB RS, Approved before 1982 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 A061621-001 ERYTHROMYCIN 250MG TABLET / ORAL AB Approved before 1982 782e0a99824c…2021-12-28 21:50 UTC 2021-12 A061621-002 ERYTHROMYCIN 500MG TABLET / ORAL AB RS, Approved before 1982 782e0a99824c…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 3 · 82 observed states.
DailyMed Product Concepts# FDA-Initiated Inactive NDC Indexing# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 21695-457-15 ERY-TAB 15 in 1 BOTTLE TABLET, DELAYED RELEASE 15 1 21695-457-21 ERY-TAB 21 in 1 BOTTLE TABLET, DELAYED RELEASE 21 1 21695-457-30 ERY-TAB 30 in 1 BOTTLE TABLET, DELAYED RELEASE 30 1
DailyMed Socrata Ingredients# Ingredient, Type, UNII table Ingredient Type UNII DailyMed label SPL version Uploaded erythromycin ACTIVE INGREDIENT 63937KV33D ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [REBEL DISTRIBUTORS CORP] 1 erythromycin ACTIVE MOIETY 63937KV33D ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [REBEL DISTRIBUTORS CORP] 1 AMMONIA INACTIVE INGREDIENT 5138Q19F1X ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [REBEL DISTRIBUTORS CORP] 1 CELLULOSE, MICROCRYSTALLINE INACTIVE INGREDIENT OP1R32D61U ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [REBEL DISTRIBUTORS CORP] 1 CROSCARMELLOSE SODIUM INACTIVE INGREDIENT M28OL1HH48 ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [REBEL DISTRIBUTORS CORP] 1 CROSPOVIDONE INACTIVE INGREDIENT 68401960MK ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [REBEL DISTRIBUTORS CORP] 1 HYDROXYPROPYL CELLULOSE INACTIVE INGREDIENT RFW2ET671P ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [REBEL DISTRIBUTORS CORP] 1 HYPROMELLOSE PHTHALATE (24% PHTHALATE, 55 CST) INACTIVE INGREDIENT 87Y6436BKR ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [REBEL DISTRIBUTORS CORP] 1 HYPROMELLOSES INACTIVE INGREDIENT 3NXW29V3WO ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [REBEL DISTRIBUTORS CORP] 1 magnesium stearate INACTIVE INGREDIENT 70097M6I30 ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [REBEL DISTRIBUTORS CORP] 1 POVIDONE INACTIVE INGREDIENT FZ989GH94E ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [REBEL DISTRIBUTORS CORP] 1 propylene glycol INACTIVE INGREDIENT 6DC9Q167V3 ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [REBEL DISTRIBUTORS CORP] 1 SILICON DIOXIDE INACTIVE INGREDIENT ETJ7Z6XBU4 ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [REBEL DISTRIBUTORS CORP] 1 sodium citrate INACTIVE INGREDIENT 1Q73Q2JULR ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [REBEL DISTRIBUTORS CORP] 1 SORBITAN MONOOLEATE INACTIVE INGREDIENT 06XEA2VD56 ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [REBEL DISTRIBUTORS CORP] 1 talc INACTIVE INGREDIENT 7SEV7J4R1U ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [REBEL DISTRIBUTORS CORP] 1 titanium dioxide INACTIVE INGREDIENT 15FIX9V2JP ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [REBEL DISTRIBUTORS CORP] 1
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 21695-457 ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [REBEL DISTRIBUTORS CORP] 1 Legacy NDC, 3 package rows 20101126_e142a363-a8b8-40b9-ae9d-28777367e718.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 3 matching rows.
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Status 21695-457-15 21695045715 15 in 1 BOTTLE Historical 21695-457-21 21695045721 21 in 1 BOTTLE Historical 21695-457-30 21695045730 30 in 1 BOTTLE Historical